ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,166, issued on Feb. 3, was assigned to Bimyo GmbH (Monheim, Germany).
"BNIP3 peptides for treatment of reperfusion injury" was invented by Tienush Rassaf (Essen, Germany) and Ulrike Hendgen-Cotta (Dinslaken, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides peptides capable of inhibiting the individual activity and inter-pathway communication of BNIP3, BAX and mitochondria. The peptides can be used in methods of treating a disease or condition in a subject in which it is desirable to prevent cell damage and cell death."
The patent was filed on May 8, 2020, under Application No. 17/608,655.
*For further information, inclu...